Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/1999
06/24/1999WO1999030732A1 Gamma-conopeptides
06/24/1999WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression
06/24/1999WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
06/24/1999WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
06/24/1999WO1999030699A1 Modulators of cysteine protease
06/24/1999WO1999030694A2 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
06/24/1999WO1999030687A1 Pharmaceutical compositions containing micronized bicyclic drugs
06/24/1999WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
06/24/1999WO1999030560A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
06/24/1999WO1999030548A2 Method for the preparation of citalopram
06/24/1999WO1999019305A3 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
06/24/1999DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc.
06/24/1999DE19756036A1 New indole amide derivatives
06/24/1999CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor
06/24/1999CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
06/24/1999CA2315540A1 Agonists of metabotropic glutamate receptors and uses thereof
06/24/1999CA2315295A1 110 human secreted proteins
06/24/1999CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
06/24/1999CA2315079A1 Substituted isoquinoline derivatives and their use as anticonvulsants
06/24/1999CA2314968A1 Pharmaceutical compositions containing micronized bicyclic drugs
06/24/1999CA2314948A1 Potassium channel openers
06/24/1999CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression
06/24/1999CA2314686A1 Gamma-conopeptides
06/24/1999CA2314379A1 Human dendriac and brainiac-3
06/24/1999CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors
06/24/1999CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity
06/24/1999CA2313651A1 Benzamine derivatives
06/24/1999CA2313448A1 Ubiquitin-like conjugating protein
06/24/1999CA2313212A1 Modulators of cysteine protease
06/24/1999CA2313125A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
06/24/1999CA2313004A1 3-substituted adenines via2-thioxanthines
06/23/1999EP0924297A1 Sialoadhesin family member-2 (saf-2)
06/23/1999EP0924219A2 Novel estrenes for inducing hypothalamic effects
06/23/1999EP0924211A2 1,2 bridged 1,4-dihydropyridines as selective potassium channel modulators
06/23/1999EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor
06/23/1999EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases
06/23/1999EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives
06/23/1999EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
06/23/1999EP0923576A1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
06/23/1999EP0923573A1 Preparation of aminomethyl-phenylimidazoles
06/23/1999EP0923569A1 Butyric acid matrix metalloproteinase inhibitors
06/23/1999EP0923567A1 Benzylamine derivatives, their preparation and their application in therapeutics
06/23/1999EP0923552A1 Pyranoindole and carbazole inhibitors of cox-2
06/23/1999EP0923551A1 4-aminoethoxy indolone derivatives
06/23/1999EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
06/23/1999EP0923549A1 Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
06/23/1999EP0923548A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a? ligands
06/23/1999EP0923545A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
06/23/1999EP0923542A1 Aryl substituted cyclic amines as selective dopamine d3 ligands
06/23/1999EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
06/23/1999EP0923379A1 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution
06/23/1999EP0923373A1 Il-8 receptor antagonists
06/23/1999EP0923370A2 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
06/23/1999EP0671915B1 Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development
06/23/1999EP0636024B1 Potentiation of antimicrobial effects
06/23/1999EP0502117B1 Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone
06/23/1999CN1220656A Novel trienoic retinoid compounds and method
06/23/1999CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof
06/23/1999CN1220265A New piperazine and piperidine compounds
06/23/1999CN1220160A Dizziness-stopping analgesic
06/23/1999CN1043764C Bicycle carboxamides as 5-HT1A antagonists
06/23/1999CN1043763C Tropane-aldoxine derivatives and preparation process and use thereof
06/23/1999CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition
06/23/1999CN1043759C Process for preparation of 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
06/22/1999US5914425 Modifications of 2-amino-4-(4-5fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation
06/22/1999US5914338 Heterocyclic compounds and their preparation and use
06/22/1999US5914333 Treatment of psychotic disorders
06/22/1999US5914329 Dimesylate salts of neuropeptide Y ligands
06/22/1999US5914118 Multi-layered drug containing film preparation having powder adhesive thereon
06/22/1999CA2151674C Methods of administering crf antagonists
06/20/1999CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease
06/20/1999CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases
06/17/1999WO1999029697A1 Pharmaceuticals
06/17/1999WO1999029696A1 Piperidine derivatives
06/17/1999WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999WO1999029657A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
06/17/1999WO1999029323A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999016460A3 Apolipoprotein e/growth factor complexes and methods of use
06/17/1999WO1999016442A3 Sustained release tablet formulation to treat parkinson disease
06/17/1999WO1999004237A3 Diagnosis of spongiform encephalopathies using prionins
06/17/1999DE19755268A1 Benzamidinderivate Benzamidine derivatives
06/17/1999CA2313236A1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides, corresponding acids, and uses
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312844A1 Pharmaceuticals
06/17/1999CA2312760A1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
06/16/1999EP0922703A1 Substituted heterocyclic benzocycloalkenes and their use as analgesically active compounds
06/16/1999EP0922460A1 Neuro-Function regulatory agent comprising glycosyl vitamin P
06/16/1999EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
06/16/1999EP0922044A1 Pyrrolo(3,2-c) quinoline derivatives
06/16/1999EP0922035A1 Tetrahydroisoquinoline derivatives and their pharmaceutical use
06/16/1999EP0922034A1 Tetrahydroquinoline derivatives as eaa antagonists
06/16/1999EP0922029A1 Ether muscarinic antagonists
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921800A1 Substituted biphenyl isoxazole sulfonamides
06/16/1999EP0921790A1 Sulfonyl fluorides for the treatment of alzheimer's disease
06/16/1999EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor
06/16/1999EP0711283B1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
06/16/1999EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
1 ... 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 ... 1833